People with metabolic dysfunction-associated steatotic liver disease (MASLD) who drink heavily at least once a month face higher odds of advanced liver scarring than…
Fatty liver disease
FATTY LIVER DISEASE
ColumnsFearing liver cancer when you’re living with fatty liver disease
Yesterday, as I puttered around my house doing some spring cleaning, I watched a gray, rainy sky turn to snow. The flakes were the chunky…
FATTY LIVER DISEASE
NewsTrial of WVE-007 for obesity aims to inform decisions about drug for MASH
An upcoming portion of an ongoing clinical trial that will test Wave Life Sciences’ WVE-007 in adults with obesity and related health problems will…
FATTY LIVER DISEASE
ColumnsGrappling with sudden change after a liver disease diagnosis
My childhood home was a warm place with two loving parents, my siblings, our pets, and a steady stream of family members and friends constantly…
FATTY LIVER DISEASE
NewsHK2 protein identified as potential treatment target for MASH: Study
Two proteins called S100A11 and HK2 contribute to the abnormal buildup of fat in the liver that characterizes steatotic liver disease (SLD), according to…
FATTY LIVER DISEASE
ColumnsVitamins play a key role in liver health, so monitoring your levels is crucial
Note: This column describes the author’s own experiences with vitamin supplementation. Not everyone will have the same response to treatment. Consult your doctor before starting…
FATTY LIVER DISEASE
NewsTrial of combo therapy for MASH-related cirrhosis to start this year
Sagimet Biosciences said it expects a clinical trial testing a combination therapy in people with cirrhosis, or irreversible liver scarring, due to metabolic dysfunction-associated steatohepatitis…
FATTY LIVER DISEASE
ColumnsLiving with MASH reminds me to avoid making assumptions
I’m not perfect. Sure, I’d love to possess the unshakable confidence of people who seem convinced they are, but I’ve learned to accept most of…
FATTY LIVER DISEASE
NewsHuman trial testing gene silencing injection therapy for MASH kicks off
The first participant has been dosed in a large clinical trial testing TGM-312, a novel gene-silencing therapy designed to slow the progression of metabolic dysfunction-associated…
FATTY LIVER DISEASE
ColumnsDon’t let liver disease keep you from chasing your dreams
After struggling with my health for years, mainly due to metabolic dysfunction-associated steatohepatitis (MASH), my life has taken a dramatic turn for the better.
Recent Posts
- Let’s go to the movies and forget about living with chronic illness for a day
- Remembering to always pack my son’s meds was a hard lesson to learn
- When exploring MASH research, follow the science and the money
- Guest Voice: I donated a part of my liver. You can, too!
- Cats don’t get MASH, but they can still get fatty liver disease